Please ensure Javascript is enabled for purposes of website accessibility

SEC Filing Details

Document Details

Form
Filing Date
Feb 22, 2023
Document Date
Feb 22, 2023
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Apellis Pharmaceuticals, Inc.
Issuer
APELLIS PHARMACEUTICALS, INC.